Coming of age for monitoring quality of life and patient-reported outcomes.

In this issue of the Journal of Thoracic Oncology, Yang et al.1 contribute knowledge of importance to all of us treating lung cancer, and their findings may have larger implications for monitoring and analysis in many areas of cancer therapy. By incorporating quality of life (QOL) and patient-reported outcome (PRO) assessment into an analysis of lung cancer… CONTINUE READING